JPM vs MET
By Alex · Tickerpine
JPMorgan Chase & Co. vs MetLife, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JPM | MET |
|---|---|---|
| Price | $329.05 | $85.95 |
| Market cap | $881.69B | $55.30B |
| P/E ratio | 15.8 | 16.6 |
| ROE | 16.47% | 13.01% |
| Profit margin | 33.94% | 4.67% |
| Revenue growth | 12.70% | 2.70% |
| Dividend yield | 1.82% | 2.76% |
| Beta | 1.00 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JPM vs MET in plain English
- JPM is the bigger company — about 15.9× the market cap of MET.
- JPM is cheaper on earnings (P/E 15.8 vs 16.6).
- JPM earns a higher return on equity (16% vs 13%).
- JPM is growing revenue faster (13% vs 3%).
- MET has the higher dividend yield (2.76% vs 1.82%).
How would $1,000 have done in each?
JPM return calculator
See what $1,000 in JPMorgan Chase & Co. would be worth today.
MET return calculator
See what $1,000 in MetLife, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.